1 minute read
Scope and Methodology
Report DescriptionAbout IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Advertisement
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report DescriptionReport Description and Highlights
According to the latest report by IMARC Group, titled "Artificial Pancreas Device Systems (APDS)
Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-
2027," the global artificial pancreas device systems market reached a value of US$ 1,949 Million in 2021.
Artificial pancreas device systems (APDS) refer to a diabetes management system that is designed to regulate blood glucose levels in the human body. These systems mimic the functioning of a healthy pancreas with the help of a continuous glucose monitor (CGM) and an insulin infusion pump.
The CGM, along with a sensor that is subcutaneously placed under the patient's skin, is utilized to track blood glucose levels and to determine the required insulin level of the body by evaluating realtime glucose readings. In case insulin deficit is registered by the CGM, the computer-controlled algorithm of the system sends an alert to the infusion pump that delivers the appropriate amount of insulin required by the body throughout the day in controlled amounts.
Request for a PDF sample of this report: https://www.imarcgroup.com/artificial-pancreas-devicesystems-market/requestsample
